COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Shisha Smoking on the Biology of the Airway Epithelium in Qatar

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02021708
Recruitment Status : Completed
First Posted : December 27, 2013
Last Update Posted : April 29, 2016
Sponsor:
Collaborators:
Weill Cornell Medical College in Qatar
Hamad Medical Corporation
Information provided by (Responsible Party):
Weill Medical College of Cornell University

Brief Summary:
The purpose of this study is to learn about the effects of smoking shisha on the lungs, when compared to the effects of smoking cigarettes or of not smoking. The investigators hope to learn more about how shisha smokers should be monitored and treated once diseased.

Condition or disease
Smoking

Detailed Description:
Traditional shisha smoking is practiced by ~10% of the Qatari adult population. Although based on tobacco leaves, shisha smoking exposes the airway epithelium to a chemical insult of intensity and duration different from that of cigarette smoking. This study, a collaboration between WCMC-Qatar and WCMC-New York and the Hamad Medical Corporation (HMC), is focused on defining the biology of the airway epithelium of shisha smokers compared to non-smokers. Using approved protocols, bronchoscopy will be used to sample the airway epithelium, the site of the earliest changes associated with smoking. The transcriptome of the recovered epithelium will be assessed in the genomic core WCMC-Qatar for gene expression using microarrays and complete RNA sequencing using massive parallel sequencing.Based on this information, the epithelial DNA will be assessed for relevant SNPs, copy number variations and methylation status. Parallel studies will be carried out in cigarette smokers, providing a comprehensive catalog of shisha smoking-induced changes compared to cigarette smokers and non-smokers in this population.

Layout table for study information
Study Type : Observational
Actual Enrollment : 64 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Effect of Shisha Smoking on the Biology of the Airway Epithelium in Qatar
Study Start Date : January 2013
Actual Primary Completion Date : January 2016
Actual Study Completion Date : January 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Smoking

Group/Cohort
Non-smoker
This group will include individuals without any history of lung disease, including asthma, and without recurrent or acute pulmonary disease. Individuals must also have smoked less than 100 cigarettes and/or less than 10 shisha pipes in their lifetime.
Shisha smoker
This group will include individuals who have a shisha smoking history of more than 5 pipe-years and must currently smoke more than 5 pipes per week. Individuals must not show any signs of acute lung infection or have medical history of significant illness or other significant medical issues.
Cigarette smoker
This group will include individuals who have a cigarette smoking history that will be confirmed by urine testing. Individuals must not show any signs of acute lung infection or have medical history of significant illness or other significant medical issues.



Primary Outcome Measures :
  1. Gene expression changes in the small airway epithelium (SAE) [ Time Frame: 3 days ]
    We will measure the effect that shisha smoking has on the small airway epithelium (SAE) by measuring parameters such as the SAE gene expression in shisha smokers (i.e., non-cigarette smokers). We will compare these parameters to the same parameters measured in non-smokers and cigarette smokers.


Biospecimen Retention:   Samples With DNA
Blood


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Subjects will be recruited in the pulmonary and smoking cessation clinics of HMC.
Criteria

Non-smoker

Inclusion Criteria:

  • Population living in Qatar
  • Must provide informed consent
  • Individuals must also have smoked less than 100 cigarettes and/or less than 10 shisha pipes in their lifetime
  • Has normal pulmonary function test
  • Has normal chest xray
  • No signs of acute lung infection

Exclusion Criteria:

  • Medical history of significant illness or other significant medical issues
  • Regular shisha smoker
  • Regular cigarette smoker
  • Simultaneous cigarette plus shisha smoking

Shisha smoker

Inclusion Criteria:

  • Population living in Qatar
  • Must provide informed consent
  • Must have smoked 5 pipe-yr
  • Must currently smoke 5 pipes/wk
  • Has normal function tests
  • Has normal chest xray
  • No signs of acute lung infection

Exclusion Criteria:

  • Medical history of significant illness or other significant medical issues
  • Regular cigarette smoker
  • Simultaneous cigarette plus shisha smoking

Cigarette smoker

Inclusion Criteria:

  • Population living in Qatar
  • Must provide informed consent
  • Confirmation of smoking status by urine testing
  • Confirmation of smoking status by assessment of carboxyhemoglobin
  • Has normal function tests
  • Has normal chest xray
  • No signs of acute lung infection

Exclusion Criteria:

  • Medical history of significant illness or other significant medical issues
  • Regular shisha smoker
  • Simultaneous cigarette plus shisha smoking

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02021708


Locations
Layout table for location information
Qatar
Hamad Medical Corporation
Doha, Qatar
Sponsors and Collaborators
Weill Medical College of Cornell University
Weill Cornell Medical College in Qatar
Hamad Medical Corporation
Investigators
Layout table for investigator information
Principal Investigator: Matthew Walters, PhD Weill Medical College of Cornell University
Layout table for additonal information
Responsible Party: Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT02021708    
Other Study ID Numbers: 13-00055 [JIRB]
NPRP 09-742-3-194 ( Other Identifier: Qatar National Research Fund )
First Posted: December 27, 2013    Key Record Dates
Last Update Posted: April 29, 2016
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided